WST
West Pharmaceutical Services Inc
NYSE: WST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$297.59
+0.76% today
Updated 2026-04-30
Market cap
$20.64B
P/E ratio
39.05
P/S ratio
6.41x
EPS (TTM)
$7.48
Dividend yield
0.28%
52W range
$202 – $322
Volume
0.9M
West Pharmaceutical Services Inc (WST) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $143.80M | $129.20M | $135.00M | $137.70M | $138.30M | $130.70M | $187.40M | $220.50M | $182.90M | $212.40M | $219.40M | $263.30M | $288.60M | $367.20M | $472.50M | $584.00M | $724.00M | $776.50M | $653.40M | $754.80M |
| Capital expenditures | $90.30M | $129.40M | $139.10M | $107.80M | $73.80M | $96.80M | $132.00M | $155.80M | $112.10M | $131.60M | $170.20M | $130.80M | $104.70M | $126.40M | $174.40M | $253.40M | $284.60M | $362.00M | $377.00M | $285.90M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $900000.00 | $11.80M | $6.40M | $7.50M | $7.80M | $8.40M | $15.50M | $21.20M | $18.60M | $29.60M | $19.50M | $16.10M | $15.10M | $24.40M | $34.00M | $37.50M | $23.70M | $23.30M | $18.70M | $23.80M |
| Free cash flow | $53.50M | $-200000.00 | $-4.10M | $29.90M | $64.50M | $33.90M | $55.40M | $64.70M | $70.80M | $80.80M | $49.20M | $132.50M | $183.90M | $240.80M | $298.10M | $330.60M | $439.40M | $414.50M | $276.40M | $468.90M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $15.90M | $17.50M | $18.60M | $20.10M | $21.70M | $23.20M | $24.90M | $26.80M | $29.10M | $32.40M | $35.80M | $39.10M | $42.10M | $45.10M | $48.10M | $51.10M | $54.10M | $57.00M | $59.10M | $61.20M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $27.10M | $-18.40M | $70.10M | $68.10M | $25.30M | $19.30M | $-71.60M | $32.90M | $101.50M | $101.70M | $176.40M | $147.10M | $142.20M | — | — | — |